Coming in February: AACR posts its itinerary planner in early February 2027 and the abstracts in early March. We’ll add the program and the organizations presenting it once they’re out.

Targeted therapy at AACR 2027

Apr 2–7, 2027 Orlando, FL ~23k attendees Website

21 organizations at AACR 2027 present work in targeted therapy. 21 of them have their own page in this guide. As of Sep 27, 2026.

All 427 organizations at AACR 2027 →

Showing 1–20 of 21 organizations

Organization	AACR 2027 Attendance
AbbVie Mettawa, IL
abbvie.com Pharma Global biopharma whose cancer medicines include targeted drugs for blood cancers and antibody-drug conjugates for solid tumors.	Booth Exhibiting at Booth 2643 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Amgen Thousand Oaks, CA
amgen.com Pharma Large independent biotechnology company developing medicines for serious diseases, including cancer.	Booth Exhibiting at Booth 1934 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
AstraZeneca Cambridge, UK
astrazeneca.com Pharma Global biopharma with a large oncology portfolio spanning targeted therapies, antibody-drug conjugates and immunotherapies.	Booth Exhibiting at Booth 1943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Bayer Leverkusen, Germany
bayer.com Pharma Pharmaceutical and life sciences company whose oncology franchise prioritizes cancer targets and pathways with potential to change how cancer is treated.	Booth Exhibiting at Booth 1043 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
BeOne Medicines San Carlos, CA
beonemedicines.us Pharma Global oncology company with blood cancer and solid tumor medicines, including a BTK inhibitor and a PD-1 antibody, and a broad pipeline.	Booth Exhibiting at Booth 2833 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Boehringer Ingelheim Ingelheim am Rhein, Germany
boehringer-ingelheim.us Pharma Global drugmaker whose oncology pipeline pairs therapies aimed at cancer cells with immuno-oncology approaches, alone and in combination.	Booth Exhibiting at Booth 2381 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Eilean Therapeutics Dover, DE
eileanther.com Biotech Clinical-stage small-molecule oncology developer targeting drug-resistance mechanisms in blood cancers and solid tumors, including KRAS, menin and BCL2 programs.	Booth Exhibiting at Booth 1657 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Eli Lilly Indianapolis, IN
lilly.com Pharma Global pharmaceutical company with medicines in cancer, diabetes, obesity, Alzheimer's disease and immunology.	Booth Exhibiting at Booth 1443 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
EMD Serono Boston, MA
emdserono.com Pharma US and Canadian healthcare business of Merck KGaA, Darmstadt, Germany, whose oncology research targets hard-to-treat tumor types.	Booth Exhibiting at Booth 1554 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Exelixis Alameda, CA
exelixis.com Pharma Oncology company known for cabozantinib, with a pipeline of small-molecule drugs, ADCs and biologics for a widening range of tumor types.	Booth Exhibiting at Booth 2825 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Fore Biotherapeutics Philadelphia, PA
fore.bio Biotech Clinical-stage company developing plixorafenib, a next-generation BRAF inhibitor that avoids paradoxical MAPK activation, in a phase 2 basket trial for BRAF-altered cancers.	Booth Exhibiting at Booth 2107 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Genentech South San Francisco, CA
gene.com Pharma Roche Group member that discovers, develops, manufactures and markets medicines for serious and life-threatening conditions.	Booth Exhibiting at Booth 2243 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
GSK London, UK
gsk.com Pharma Global drugmaker growing its oncology work in blood cancers, gynecologic cancers and other solid tumors through immuno-oncology and tumor-targeting medicines.	Booth Exhibiting at Booth 943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Incyte Wilmington, DE
incyte.com Pharma Biopharma known for JAK and other targeted cancer medicines, with a pipeline in oncology and in inflammation and autoimmunity, mostly discovered in-house.	Booth Exhibiting at Booth 1143 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Insilico Medicine Cambridge, MA
insilico.com Biotech Drug developer that uses its own generative-AI platform for target discovery, molecule design and clinical planning to build a pipeline of new drug candidates.	Booth Exhibiting at Booth 907 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Johnson & Johnson New Brunswick, NJ
jnj.com Pharma Healthcare company spanning Innovative Medicine and MedTech; its oncology portfolio includes cell therapy, bispecific antibodies and targeted drugs for myeloma, lung and prostate cancer.	Booth Exhibiting at Booth 2443 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Novartis Basel, Switzerland
novartis.com Pharma Swiss medicines company whose oncology portfolio spans targeted therapies such as Kisqali, radioligand therapies and CAR-T cell therapy.	Booth Exhibiting at Booth 650 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Pfizer New York, NY
pfizer.com Pharma Oncology unit with marketed and pipeline antibody-drug conjugates, small-molecule targeted drugs and bispecific immunotherapies across breast, genitourinary, hematologic, lung and other cancers.	Booth Exhibiting at Booth 1243 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Revolution Medicines Redwood City, CA
revmed.com Biotech Oncology drug developer in late-stage trials with RAS(ON) inhibitors aimed at the many oncogenic RAS variants that drive RAS-addicted cancers.	Booth Exhibiting at Booth 2607 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm
Stemline New York, NY
stemline.com Pharma Menarini Group's commercial oncology company, marketing treatments such as an oral SERD for ER-positive breast cancer and a CD123-directed therapy for a rare blood cancer.	Booth Exhibiting at Booth 2503 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm

Instantly find 20 buyers in targeted therapy

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction

Instantly find 20 buyers in targeted therapy

Browse AACR 2027 by